Immunome, Inc. (IMNM) vs Recursion Pharmaceuticals, Inc. (RXRX)

• Immunome, Inc. IMNM 18.65 ▲ +4.13%
• Recursion Pharmaceuticals, Inc. RXRX 3.52 ▲ +0.57%

Immunome, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Immunome, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.1B). Recursion Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 56.2% against 16.7%. Immunome, Inc. has the higher net margin (0.00% vs −697.1%) and the lower return on invested capital (−3,323.0% vs −88.5%). Across the 17 metrics below, Immunome, Inc. leads on 9 and Recursion Pharmaceuticals, Inc. on 8.